시간 외 거래: 1.98

오큐젠 (OCGN)

Ocugen Inc 주식(OCGN)의 최신 뉴스

오큐젠 (OCGN)

Ocugen Inc 주식(OCGN)의 최신 뉴스

Ocugen (NASDAQ:OCGN) Shares Gap Down to $1.96 - MarketBeat

Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important ... - GlobeNewswire

Ocugen Advances with Phase 1/2 Trial for Stargardt Disease Treatment - MyChesCo

Ocugen Advances Gene Therapy Trials, Targets 2026 for Key Regulatory Approvals - MyChesCo

Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch

Ocugen completes second cohort dosing in Stargardt trial - Investing.com India

Ocugen completes second cohort dosing in Stargardt trial - Investing.com

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen - GlobeNewswire

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen - StreetInsider.com

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen - Morningstar

Ocugen, Inc. (NASDAQ:OCGN) Q1 2024 Earnings Call Transcript - Insider Monkey

4 Analysts Assess Ocugen: What You Need To Know - Ocugen (NASDAQ:OCGN) - Benzinga

Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical ... - Ocugen

Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical ... - GlobeNewswire

Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact ... - PR Newswire

Earnings call: Ocugen reports progress in gene therapy trials and Q1 financials - Investing.com

Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch

Ocugen: Q1 Earnings Snapshot - Milford Mirror

OCGN Stock Earnings: Ocugen Beats EPS for Q1 2024 - InvestorPlace

Ocugen Provides Business Update with First Quarter 2024 Financial Results | Ocugen, Inc. - Ocugen

Ocugen Provides Business Update with First Quarter 2024 Financial Results - GlobeNewswire

Ocugen Provides Business Update with First Quarter 2024 Financial Results

Ocugen: Q1 Earnings Snapshot | Business | thecourierexpress.com - The Courier-Express

Ocugen: Q1 Earnings Snapshot | National | wdrb.com - WDRB

Ocugen Inc. stock rises Monday, outperforms market - MarketWatch

Ocugen to Highlight Clinical Developments at Upcoming Life Sciences Conferences - MSN

Ocugen Announces Unique Dividend Strategy with Series C Preferred Stock - MSN

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Ocugen CEO to Highlight Gene Therapy Advances at Healthcare Equity Conference - MSN

Ocugen Announces Unique Dividend Strategy with Series C Preferred Stock - MyChesCo

Implied Volatility Surging for Ocugen (OCGN) Stock Options - Yahoo News UK

Ocugen to Highlight Clinical Developments at Upcoming Life Sciences Conferences - MyChesCo

Ocugen (OCGN) Set to Announce Quarterly Earnings on Tuesday - Defense World

Ocugen Inc. stock falls Friday, underperforms market - MarketWatch

ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline ... - PR Newswire

Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock - GlobeNewswire

Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

OCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ocugen, Inc. Investors with Substantial ... - GlobeNewswire

OCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ocugen, Inc. Investors with Substantial ... - GlobeNewswire

Ocugen to Present at May 2024 Investor Conferences - WICZ

Ocugen to Present at May 2024 Investor Conferences - GlobeNewswire

Ocugen to Present at May 2024 Investor Conferences - Yahoo Finance

OCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Ocugen, Inc. Investors to Join the Class ... - AccessWire

Ocugen Inc. stock falls Thursday, underperforms market - MarketWatch

ROSEN, A RANKED AND LEADING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important ... - The Globe and Mail

Ocugen Inc. stock rises Wednesday, outperforms market - MarketWatch

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm - Barron's

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen - GlobeNewswire

OCGN과 유사한 종목